Literature DB >> 17514584

Negative regulation of corticotropin releasing factor expression and limitation of stress response.

Greti Aguilera1, Alexander Kiss, Ying Liu, Anna Kamitakahara.   

Abstract

Corticotropin releasing factor (CRF) coordinates behavioral, autonomic and hormonal responses to stress. Activation of the hypothalamic pituitary adrenal (HPA) axis with stimulation of CRF and vasopressin (VP) release from hypothalamic parvocellular neurons, and consequent secretion of ACTH from the anterior pituitary and glucocorticoid from the adrenal cortex, is the major endocrine response to stress. Current evidence indicates that the main regulator of ACTH secretion in acute and chronic conditions is CRF, in spite of the fact that the selective increases in expression of parvocellular VP and pituitary VP V1b receptors observed during prolonged activation of the HPA axis have suggested that VP becomes the predominant regulator. Following CRF release, activation of CRF transcription is required to restore mRNA and peptide levels, but termination of the response is essential to prevent pathology associated with chronic elevation of CRF and glucocorticoid production. While glucocorticoid feedback plays an important role in regulating CRF expression, the relative importance of direct transcriptional repression of the CRF gene by glucocorticoids in the overall feedback mechanism is not clear. In addition to glucocorticoids, intracellular feedback mechanisms in the CRF neuron, involving induction of repressor forms of cAMP response element modulator (CREM) limit CRF transcriptional responses by competing with the positive regulator, phospho-CREB. Rapid repression of CRF transcription following stress-induced activation is likely to contribute to limiting the stress response and to preventing disorders associated with excessive CRF production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17514584     DOI: 10.1080/10253890701391192

Source DB:  PubMed          Journal:  Stress        ISSN: 1025-3890            Impact factor:   3.493


  22 in total

Review 1.  The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis.

Authors:  Li-Chun Lisa Tsai; Joseph A Beavo
Journal:  Curr Opin Pharmacol       Date:  2011-09-29       Impact factor: 5.547

2.  Sexually diergic, dose-dependent hypothalamic-pituitary-adrenal axis responses to nicotine in a dynamic in vitro perfusion system.

Authors:  Jessica M McKlveen; Jared M Wilson; Robert T Rubin; Michael E Rhodes
Journal:  J Pharmacol Toxicol Methods       Date:  2010-02-01       Impact factor: 1.950

3.  The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland.

Authors:  Li-Chun Lisa Tsai; Masami Shimizu-Albergine; Joseph A Beavo
Journal:  Mol Pharmacol       Date:  2010-12-27       Impact factor: 4.436

4.  Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes.

Authors:  E Keen-Rhinehart; V Michopoulos; D J Toufexis; E I Martin; H Nair; K J Ressler; M Davis; M J Owens; C B Nemeroff; M E Wilson
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

5.  Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice.

Authors:  Evan Elliott; Gili Ezra-Nevo; Limor Regev; Adi Neufeld-Cohen; Alon Chen
Journal:  Nat Neurosci       Date:  2010-10-03       Impact factor: 24.884

6.  3xTg-AD mice exhibit an activated central stress axis during early-stage pathology.

Authors:  Elaine K Hebda-Bauer; Tracy A Simmons; Andrew Sugg; Eren Ural; James A Stewart; James L Beals; Qiang Wei; Stanley J Watson; Huda Akil
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 7.  Regulation of adrenal steroidogenesis by the high-affinity phosphodiesterase 8 family.

Authors:  L-C L Tsai; J A Beavo
Journal:  Horm Metab Res       Date:  2012-08-17       Impact factor: 2.936

8.  Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator.

Authors:  Ioannis Zalachoras; René Houtman; Erika Atucha; Rene Devos; Ans M I Tijssen; Pu Hu; Peter M Lockey; Nicole A Datson; Joseph K Belanoff; Paul J Lucassen; Marian Joëls; E Ronald de Kloet; Benno Roozendaal; Hazel Hunt; Onno C Meijer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-23       Impact factor: 11.205

9.  Stress hormone synthesis in mouse hypothalamus and adrenal gland triggered by restraint is dependent on pituitary adenylate cyclase-activating polypeptide signaling.

Authors:  N Stroth; L E Eiden
Journal:  Neuroscience       Date:  2009-11-18       Impact factor: 3.590

10.  No variation of physical performance and perceived exertion after adrenal gland stimulation by synthetic ACTH (Synacthen) in cyclists.

Authors:  Norbert Baume; Graeme Steel; Tony Edwards; Eric Thorstensen; Benjamin F Miller
Journal:  Eur J Appl Physiol       Date:  2008-06-27       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.